Dr. Ann-Marie Richard

Dr. Ann-Marie Richard has a diverse and extensive work experience. Dr. Ann-Marie started their career at Autoimmune Inc. as an Associate Scientist, where they investigated the mechanism of Oral Tolerance in the treatment of autoimmune diseases. Dr. Ann-Marie then worked at Boston University School of Medicine as an Instructor of Medicine, where they conducted research on the role of tumor necrosis factor-alpha in protecting beta cell function in type 1 diabetes.

After that, Dr. Richard joined Wyeth Vaccines Research, where they held various roles as a Senior Research Scientist and contributed to establishing protocols and experimental techniques in the laboratory. Dr. Ann-Marie then moved on to work at Pfizer, where they held multiple roles, including as a Principal Scientist and Research Project Leader for cardiovascular, metabolic, and endocrine diseases. In these roles, they conducted research on diabetes and led in vivo and ex-vivo assay development for evaluating novel peptides and targets. Dr. Ann-Marie also served as the Director and Patient Engagement Lead at Pfizer, where they integrated patient and caregiver perspectives into research and development strategies.

Outside of their industry work, Dr. Richard founded the Dominican Health and Education Initiative (DAHEI), a non-profit organization focused on improving health and education standards in Dominica.

Overall, Dr. Ann-Marie Richard has demonstrated a strong background in research and development, with a focus on cardiovascular, metabolic, and endocrine diseases, and a commitment to patient engagement and improving health standards.

Dr. Ann-Marie Richard holds a Ph.D. in Pathology, which they obtained from Boston University School of Medicine between 1997 and 2003. Dr. Ann-Marie also completed their undergraduate education at Suffolk University, where they earned a Bachelor of Science in Biology between 1991 and 1995.